@article{merle:hal-04016442,
TITLE = {Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial},
AUTHOR = {Merle, Philippe and Blanc, Jean-Fr{\'e}d{\'e}ric and Edeline, Julien and Le Malicot, Karine and Allaire, Manon and Ass{\'e}nat, Eric and Guarssifi, Meriem and Bouattour, Mohamed and P{\'e}ron, Jean-Marie and Laurent-Puig, Pierre and Levrero, Massimo and Costentin, Charlotte and Guiu, Boris and Sokol, Harry and Tougeron, David and Aparicio, Thomas and Nault, Jean-Charles and Ph{\'e}lip, Jean-Marc},
URL = {https://hal.science/hal-04016442},
JOURNAL = {Digestive and Liver Disease},
PUBLISHER = {Elsevier},
VOLUME = {55},
NUMBER = {4},
PAGES = {pp 464-470},
YEAR = {2023},
DOI = {10.1016/j.dld.2023.01.161},
KEYWORDS = {Bevacizumab ; Hepatocellular carcinoma ; Ipilimumab ; Atezolizumab},
HAL_ID = {hal-04016442},
HAL_VERSION = {v1},
}